Marker Therapeutics, Inc. (MRKR)
1.76
+0.01
(+0.57%)
USD |
NASDAQ |
Apr 10, 15:59
1.76
0.00 (0.00%)
After-Hours: 19:47
Marker Therapeutics EPS Diluted (Quarterly) : -0.1022 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viridian Therapeutics, Inc. | -1.080 |
| Tenaya Therapeutics, Inc. | -0.1152 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| electroCore, Inc. | -0.3792 |
| Agenus, Inc. | -0.301 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.703M |
| Revenue (Quarterly) | 1.103M |
| Total Expenses (Quarterly) | 2.807M |
| Enterprise Value | 12.14M |
| Profit Margin (Quarterly) | -154.4% |
| Earnings Yield | -43.11% |
| Normalized Earnings Yield | -43.11 |